StonvexLoading…
StonvexStonvexStonvexCore line items from CBZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $2.76B | $2.22B | $1.52B | $838.01M |
Operating Income | $234.01M | $319.17M | $260.30M | $200.03M |
Net Income | $115.44M | $194.86M | $164.72M | $122.77M |
EPS (Diluted) | $1.83 | $3.06 | $2.58 | $1.91 |
Total Assets | $4.41B | $4.55B | $4.54B | $4.59B |
Total Liabilities | $2.65B | $2.67B | $2.65B | $2.67B |
Cash & Equivalents | $18.29M | $16.97M | $39.82M | $8.85M |
Free Cash Flow OCF − CapEx | $175.53M | $33.81M | $11.76M | $-93.44M |
Shares Outstanding | 54.38M | 63.61M | 63.96M | 64.14M |